Beijing successfully tested clinical influenza A / H1N1 vaccine

The work of clinical trial of A / H1N1 influenza vaccine by KeXing Beijing is progressing very smoothly, as of July 28, all tested people completed the first injection and after 3 days Safety monitoring , preliminary results show that this vaccine is safe and reliable.

The clinical trial this time of Beijing Kexing Company started from 6 am on July 22, and on July 25, the vaccination was completed for 1614 cases, including 101 cases of the elderly group. and middle-aged, adult groups are 706 cases, teenagers are 404 cases, children are 403 cases.

Currently, all people who have been tested for the first time and after 3 days of safe observation, have no bad reactions, are expected to complete the preliminary safety report in August after the first vaccination .

(Photo: cdc.gov)

This clinical trial was organized by the Chinese Center for Disease Control and the Beijing Center for Disease Control. Officials from the National Food and Drug Administration, the Ministry of Health and experts directly went to the scene to direct supervision.

According to China's current disease prevention policy, after the successful development of A / H1N1 influenza vaccine, it will temporarily not be consumed in the market. Vaccines produced are mainly for national archives, how to use or use them because of the unified government policy, the state will base on the development status of epidemics and the level of hazard, judging whether or not to use reserve vaccines.